MétaCan
Menu
Back to cohort
Record W4411732595 · doi:10.1093/bjd/ljaf085.410

British Society for Skin Care in Immunosuppressed IndividualsOral presentationsBI01 Persistent nonpruritic scabies in a patient on nemolizumab for the treatment of prurigo nodularis

2025· article· en· W4411732595 on OpenAlexaff
Bindi Gaglani, Elaine Agius, Richard Woolf, Catherine Smith, Andrew Pink

Bibliographic record

VenueBritish Journal of Dermatology · 2025
Typearticle
Languageen
FieldMedicine
TopicDermatological diseases and infestations
Canadian institutionsSt. Thomas Hospital
Fundersnot available
KeywordsPrurigo nodularisScabiesDermatologyMedicinePrurigoDermatologic agentsBiology

Abstract

fetched live from OpenAlex

Abstract Nemolizumab is a humanized monoclonal antibody that blocks interleukin (IL)-31 signalling through binding to IL-31 receptor alpha. IL-31 is a key itch cytokine and nemolizumab has proven effective at reducing pruritus and objective skin signs in atopic dermatitis and nodular prurigo. We present the case of a 38-year-old man with severe nodular prurigo who achieved complete skin clearance with no itch on nemolizumab as part of a clinical trial but developed persistent scabies on therapy. The patient was part of the OLYMPIA 1 trial ((NCT04501666) and long-term extension (NCT04204616), with nemolizumab dosed every 4 weeks. At week 132 this patient presented with a nonpruritic widespread erythematous papular rash on his feet, hands and trunk. This was initially treated as a mild eczema with topical steroids for 4 weeks, to minimal benefit. Repeat examination revealed lichenified papules on the instep of both feet and burrows with dermoscopic evidence of mites, confirming a diagnosis of scabies. The patient did not respond to monotherapy with topical permethrin 5% (and standard hot wash measures) and required a combination of oral ivermectin and topical permethrin 5% for complete clearance. He reported no household contacts and no affected family or friends. Despite complete clearance post-treatment, he developed a recurrence of the infestation 32 weeks later at week 164 and was successfully re-treated with the above regimen. The complete absence of associated pruritus (a primary hallmark of the disease) was likely a result of nemolizumab treatment. This potentially delayed presentation and diagnosis and resulted in a high mite burden and the need for repeat treatment. This case supports an important role for IL-31 in scabies-related pruritus and highlights one potential mechanism through which the often intolerable itch may be controlled. IL-31 has previously been shown to be overexpressed in scabies-affected skin as part of a predominant T helper 2 immune response (Hashimoto T, Satoh T, Yokozeki H. Pruritus in ordinary scabies: IL-31 from macrophages induced by overexpression of thymic stromal lymphopoietin and periostin. Allergy 2019; 74: 1727–37). It is important to consider the potential absence of pruritus in patients on nemolizumab when assessing new cutaneous and systemic presentations, particularly in the context of a rising prevalence of scabies in the UK.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Case report · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.040
Threshold uncertainty score0.134

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.000
Science and technology studies0.0010.000
Scholarly communication0.0010.000
Open science0.0000.001
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0400.006

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.013
GPT teacher head0.294
Teacher spread0.281 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designCase report
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueBritish Journal of DermatologySame topicDermatological diseases and infestationsFrench-language works237,207